MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 25 June 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.00664-07v1
27/17/6068    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, L.
Right arrow Articles by Hill, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, L.
Right arrow Articles by Hill, C. S.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.00664-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation

Laurence Levy, Michael Howell, Debipriya Das, Sean Harkin, Vasso Episkopou, and Caroline S. Hill*

Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, Lincoln's Inn Fields Laboratories, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom; Mammalian Neurogenesis, MRC Clinical Sciences Centre, Imperial School of Medicine, Hammersmith Hospital, London W12 0NN, UK

* To whom correspondence should be addressed. Email: caroline.hill{at}cancer.org.uk.


   Abstract

E3 ubiquitin ligases play important roles in regulating TGF-{beta}/Smad signaling. Screening of an E3 ubiquitin ligase siRNA library, using TGF-{beta} induction of a Smad3/Smad4-dependent luciferase reporter as a readout, revealed that Arkadia is an E3 ubiquitin ligase that is absolutely required for this TGF-{beta} response. Knockdown of Arkadia or overexpression of a dominant-negative mutant completely abolishes transcription from Smad3/Smad4-dependent reporters, but not from Smad1/Smad4-dependent reporters or from reporters driven by Smad2/Smad4/FoxH1 complexes. We show that Arkadia specifically activates transcription via Smad3/Smad4 binding sites by inducing degradation of the transcriptional repressor, SnoN. Arkadia is essential for TGF-{beta}-induced SnoN degradation, but has little effect on SnoN levels in the absence of signal. Arkadia interacts with SnoN and induces its ubiquitination irrespective of TGF-{beta}/Activin signaling, but SnoN is only efficiently degraded when it forms a complex with both Arkadia and phosphorylated Smad2 or Smad3. Finally, we describe an esophageal cancer cell line, SEG-1 that we show has lost Arkadia expression and is deficient for SnoN degradation. Reintroduction of wild type Arkadia restores TGF-{beta}-induced Smad3/Smad4-dependent transcription and SnoN degradation in these cells, raising the possibility that loss of Arkadia function may be relevant in cancer.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.